Company Filing History:
Years Active: 2012-2014
Title: Michelle Tetalman: Innovator in Cancer Treatment
Introduction
Michelle Tetalman is a prominent inventor based in Oakland, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of new compounds.
Latest Patents
Michelle Tetalman holds 2 patents related to Pim kinase inhibitors and methods of their use. Her latest patents focus on new compounds of Formulas I and II, including their tautomers, stereoisomers, and polymorphs. These compounds, along with their pharmaceutically acceptable salts, esters, metabolites, or prodrugs, are designed to inhibit Pim kinase activity. The inventions aim to provide effective prophylaxis or treatment of cancer, either alone or in combination with additional therapeutic agents.
Career Highlights
Michelle Tetalman is currently employed at Novartis AG, where she continues to advance her research in the pharmaceutical industry. Her work has been instrumental in developing innovative solutions for cancer treatment.
Collaborations
Some of her notable coworkers include Matthew T Burger and Jiong Lan, who contribute to her research efforts and collaborative projects.
Conclusion
Michelle Tetalman's work in developing Pim kinase inhibitors showcases her dedication to advancing cancer treatment. Her innovative patents and contributions to Novartis AG highlight her impact in the field of pharmaceuticals.